According to our report, the size of the Global Cell-Based Assay Market was worth USD 14.4 billion in 2019 and estimated to be growing at a CAGR of 11.31%, to reach USD 24.7 billion by 2024.
Cell-based assays are majorly used by biotechnology companies, academic research institutes, contract research organizations government institutions, pharmaceutical companies and others.
The cell-based assay is a technique of examining living cells on the basis of diverse parameters. Cell-based assays are used to determine virtually functions of cellular or biochemical processes. In cell-based assays, functional cells are used as analytical tools in research for novel drugs. Cell-based assays ease research in the area of immunology, stem cells, cancer and others.
Growing research activities in drug discovery, technological development, an increase in demand for biological drugs, government spending, increasing the need for toxicity screening in drugs are likely to drive the market for cell-based assays. Additionally, important advantages of a cell-based assay, innovation in technologically advanced products and need to decrease costs associated with drug discovery are anticipated to drive the market for cell-based assays.
However, short of skilled professionals, severe intellectual property rights and high cost of instruments are some of the factors restraining the growth for global cell-based assays market.
Cell based assay market is likely to expand during the forecast period owing to growth opportunities such as untapped market areas in developing countries, increasing applications of cell based assays in immunology, cancer and stem cells, and increasing adoption of label-free cell based assays.
Recent developments in this industry:
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 - 2024 |
|
Segments Covered |
By Type of Product, Technology, Application, End-User, Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
ZenRobotics, Sadako Technologies, AMP Robotics, Waste Robotics, Alpine Waste & Recycling and Resource Recycling, Bollegraaf, HOMAG, TOMRA, Pellenc ST, RES Polyflow and Optisort |
This market research report on Global Cell-Based Assay Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast until 2024.
Cell-Based Assay Market Analysis - By Type of Product
On the basis of product type, the consumables and reagent segment are ruling the market and is expected to continue the trend during the forecast period due to growing focus on drug discovery activities in developing countries leading to increasing adoption of cell-based assays in drug discovery.
Cell-Based Assay Market Analysis - By Technology
Cell-Based Assay Market Analysis - By Application
On the basis of application, the drug discovery segment is ruling the market and is likely to expand with high CAGR during the forecast period owing to rising funds for Research and development by governments and biopharmaceutical companies.
Cell-Based Assay Market Analysis - By End Users
Regional Analysis:
North America, followed by Europe, has the biggest market for cell-based assays due to rising drug-related research & development activities, an increase in adoption of cell-based assay platforms and huge number of pharmaceutical and biotechnology companies in this region. Asia is expected to show a high growth rate in the cell-based assays market in the next few years.
Top companies in the market
Few of the companies playing a dominating role in the Global Cell Based Assay Market profiled in this report are
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type of Product
5.1.1 Introduction
5.1.2 Cell Lines
5.1.2.1 Primary Cell Lines
5.1.2.2 Stem Cell Lines
5.1.2.3 Immortalized Cell Lines
5.1.3 Assay Ready Kits
5.1.4 Cell Culture Kits
5.1.5 Reagents & Consumables
5.1.6 Ligands & Inhibitors
5.1.7 Y-o-Y Growth Analysis, By Type of Product
5.1.8 Market Attractiveness Analysis, By Type of Product
5.1.9 Market Share Analysis, By Type of Product
5.2 Technology
5.2.1 Introduction
5.2.2 Automated Handling
5.2.3 Flow Cytometry
5.2.4 Label-Free Detection
5.2.5 High Content Screening
5.2.6 High Throughput Screening
5.2.7 Y-o-Y Growth Analysis, By Technology
5.2.8 Market Attractiveness Analysis, By Technology
5.2.9 Market Share Analysis, By Technology
5.3 Application
5.3.1 Introduction
5.3.2 Drug Discovery
5.3.3 ADME Research
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.4 End User
5.4.1 Introduction
5.4.2 Academia
5.4.3 Biotechnology
5.4.4 Pharmaceuticals
5.4.5 CRO
5.4.6 Y-o-Y Growth Analysis, By End User
5.4.7 Market Attractiveness Analysis, By End User
5.4.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type of Product
6.1.3.3 By Technology
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type of Product
6.1.4.3 By Technology
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technology
6.1.5.3 By Type
6.1.5.4 By Application
6.1.5.5 By End User
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Thermo Fisher Scientific Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Becton
8.3 Dickinson and Company
8.4 Merck & Co. Inc.
8.5 Cell Signalling Technology Inc.
8.6 PerkinElmer Inc.,
8.7 Danaher Corporation
8.8 General Electric Company
8.9 Cisbio Bioassays
8.10 DiscoveRx
8.11 Ametek Inc.
8.12 -Rad Laboratories
8.13 Roche Diagnostics
8.14 GE Healthcare
8.15 Promega Corporation
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Aug 2019
Download Sample
Aug 2019
Download Sample
Aug 2019
Download Sample
Aug 2019
Download Sample
